DIABREZIDE

This brand name is authorized in Ireland, Italy, Poland

Active ingredients

The drug DIABREZIDE contains one active pharmaceutical ingredient (API):

1 Gliclazide UNII G4PX8C4HKV - GLICLAZIDE

Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the β-cells of the islets of Langerhans. Read about Gliclazide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIABREZIDE Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BB09	Gliclazide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: IE	Health Products Regulatory Authority	Identifier(s): 21123
Country: IT	Agenzia del Farmaco	Identifier(s): 031844018
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100018570